STAT+: Pharmalittle: We’re reading about a Novartis gene therapy, faster U.K. drug reviews, and more
Statvia NewsData.io

Novartis acknowledged seven instances of tumors being found in children who were treated with Zolgensma for spinal muscular atrophy
Headline and summary provided via NewsData.io. The full article and its copyright belong to the original publisher.